Completed NA INTERVENTIONAL 2-arm NCT04899401

Trial To Assess Efficacy and Safety of PediaFlu® in Children With Acute Tonsillopharyngitis / Rhinopharyngitis

A Randomized, Open, Controlled Study to Evaluate the Efficacy and Safety of PediaFlù® (Dietary Supplement) Along With Standard of Care in Children With Acute Tonsillopharyngitis / Rhinopharyngitis Versus Standard of Care Only

Sponsor: Opera CRO, a TIGERMED Group Company

Conditions Rhinopharyngitis Tonsillopharyngitis

Interventions Standard of care Standard of care + PediaFlù®

Updated 6 times since 2021 Last updated: Sep 7, 2021 Started: Jun 3, 2021 Primary completion: Aug 12, 2021 Completion: Aug 12, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04899401, this NA trial focuses on Rhinopharyngitis and Tonsillopharyngitis and remains completed. Sponsored by Opera CRO, a TIGERMED Group Company, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2021 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2021 — Oct 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jun 2021 — Sep 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Opera CRO, a TIGERMED Group Company
Pediatrica S.r.l

Data source: Pediatrica S.r.l

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Timișoara, Romania